SYNEXUS Magyarorszag Kft.
- Address
- lock Available on a paid plan
Metabolic and Cardiovascular Research
At SYNEXUS Magyarorszag Kft. in Budapest, clinical trials in Nutritional and Metabolic Diseases focus on type 2 diabetes mellitus, obesity, and chronic weight management. These studies are designed to evaluate new treatments for glucose control, body weight reduction, and broader cardiovascular safety.
- Testing new therapy options for type 2 diabetes mellitus
- Evaluating treatment approaches for obesity and chronic weight management
- Assessing cardiovascular safety in people with excess weight
This area reflects a strong interest in improving long-term care for common metabolic conditions that often overlap with one another.
Gastroenterology and Inflammatory Bowel Disease
The site also supports research in Digestive System Diseases, with trials in Crohn’s disease and ulcerative colitis. These studies aim to improve symptom control, increase remission rates, and better understand the safety and effectiveness of newer immune-based therapies.
- Studying treatment effectiveness in Crohn’s disease
- Evaluating remission in ulcerative colitis
- Exploring improved options for inflammatory bowel disease
This research helps advance care for patients living with chronic intestinal inflammation and related digestive disorders.
Dermatology and Immune-Mediated Skin Disease
Clinical trials in Skin and Connective Tissue Diseases and Immune System Diseases include atopic dermatitis and moderate-to-severe plaque psoriasis. The main purpose is to test therapies that may reduce inflammation, improve skin symptoms, and support longer-term disease control.
- Investigating treatment options for atopic dermatitis
- Assessing long-term management of plaque psoriasis
- Improving control of chronic immune-mediated skin disease
The work in this field highlights a continued effort to find more effective and durable approaches for inflammatory skin conditions.
Rheumatology and Musculoskeletal Conditions
Research in Musculoskeletal Diseases at the site includes rheumatoid arthritis, psoriatic arthritis, and knee osteoarthritis. These trials are focused on reducing pain, improving joint function, and evaluating whether newer therapies can better control chronic inflammatory and degenerative joint disease.
- Studying symptom relief in rheumatoid arthritis
- Evaluating disease control in psoriatic arthritis
- Testing pain reduction strategies for knee osteoarthritis
This area combines inflammatory and structural joint disorders, offering insights into both comfort and long-term mobility.
Respiratory and Chronic Lung Disease Research
The site’s Respiratory Tract Diseases portfolio includes chronic obstructive pulmonary disease. Trials in this area are aimed at reducing flare-ups, improving daily breathing, and assessing the effectiveness of add-on treatment strategies for people with persistent lung symptoms.
- Evaluating care for chronic obstructive pulmonary disease
- Reducing exacerbations in chronic lung disease
- Improving symptom control in respiratory disease
This research supports better management of a common long-term lung condition that can significantly affect quality of life.
Neurology and Pain Management
In Nervous System Diseases, the trials focus on chronic pain due to diabetic peripheral neuropathy. The goal is to evaluate whether new treatments can provide better pain relief and improve daily functioning for people affected by nerve-related complications of diabetes.
- Studying pain relief in diabetic peripheral neuropathy
- Assessing therapies for chronic nerve pain
- Improving quality of life in neuropathic pain
This field addresses an important unmet need for patients living with persistent, diabetes-related nerve pain.
Broader Inflammatory and Immune Research
Across several therapeutic areas, the Hungary-based site is also involved in studies that examine how targeted therapies perform in chronic inflammatory disease. These trials aim to improve the understanding of treatment benefit, safety, and durability across multiple conditions.
- Supporting research in immune-mediated disease
- Comparing newer therapies with standard care
- Exploring longer-term disease control in chronic conditions
With 14 trials and 14 investigators, the site shows a broad and active commitment to clinical research across metabolic, digestive, skin, joint, respiratory, and nerve-related diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 15 of 31 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in SYNEXUS Magyarorszag Kft.
lock Showing 1 of 23 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A parallel-group treatment, proof-of-concept Phase 2, multicenter, double-blind, randomized 2 arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate or severe chronic neuropathic pain due to postherpetic neuralgia or peripheral nerve injury. | Merz Therapeutics GmbH | Phase II | Not Recruiting | Oct 2023 | Jun 2025 |
IMP list
lock Showing 1 of 31 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Paracetamol | 3 | Unknown | 2021-11-09 | 2023-10-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.